Shannon N. Westin, MD, MPH, FACOG, shares preclinical data that provided the impetus for the SOLAR trial of olaparib and selumetinib in patients with RAS-mutated gynecologic cancers, key findings from the dose-escalation and -expansion portions of the research, and next steps with the combination.
/PRNewswire/ The Lawrence J. Ellison Institute for Transformative Medicine announced today the appointment of Dr. Reva Basho as the Institute s new Director.
Ellison Institute Welcomes Dr Reva Basho as new Director of the Women s Cancer Program streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.